Ann Dermatol.  2011 Feb;23(1):53-60. 10.5021/ad.2011.23.1.53.

A Two-week Interval Is Better Than a Three-week Interval for Reducing the Recurrence Rate of Hand-foot Viral Warts after Cryotherapy: A Retrospective Review of 560 Hand-foot Viral Warts Patients

• Youn SH
• Kwon IH
• Park EJ
• Kim KH
• Kim KJ

• KMID: 2171952
• DOI: http://doi.org/10.5021/ad.2011.23.1.53

Abstract

BACKGROUND
Viral warts are a common infectious disease and liquid nitrogen cryotherapy is one of the most common methods for treatment of these warts. Hand-foot viral warts frequently recur and reduce quality of life as well.
OBJECTIVE
To find the ideal treatment interval between cryotherapy sessions that can influence not only the cure rate but also the recurrence rate for hand-foot viral warts.
METHODS
A retrospective study was designed to compare a 2 week interval and a 3 week interval between cryotherapy sessions on hand-foot viral warts with respect to cure rate, recurrence rate, treatment number, duration of treatment, mean time to recurrence and adverse events.
RESULTS
A total of 560 patients were enrolled. The overall cure rate was 75.7% and the recurrence rate was 19.6%. The mean time to recurrence was 7.8 months (range 1~26 months). For the 2-week and 3-week groups, cure rates were, respectively, 76.6% (196) and 75.0% (228); recurrence rates were 13.3% (26) and 25.0% (57). The mean time to recurrence was 9.8 months and 6.9 months, respectively. Adverse events were not statistically different.
CONCLUSION
We suggested that 2-week cryotherapy is optimal not only because of the rapid cure but also because of the lower recurrence rate and similar adverse events.

Keyword

Cryotherapy; Recurrence rate; Treatment interval; Verruca; Wart

MeSH Terms

Communicable Diseases
Cryotherapy
Humans
Nitrogen
Quality of Life
Recurrence
Retrospective Studies
Warts
Nitrogen

Figure

• 

  Fig. 1 Study design with a retrospective review.

Reference

1. Micali G, Dall'Oglio F, Nasca MR, Tedeschi A. Management of cutaneous warts: an evidence-based approach. Am J Clin Dermatol. 2004. 5:311–317.

2. Bacelieri R, Johnson SM. Cutaneous warts: an evidence-based approach to therapy. Am Fam Physician. 2005. 72:647–652.

3. Rivera A, Tyring SK. Therapy of cutaneous human papillomavirus infections. Dermatol Ther. 2004. 17:441–448.

4. Dhar SB, Rashid MM, Islam A, Bhuiyan M. Intralesional bleomycin in the treatment of cutaneous warts: a randomized clinical trial comparing it with cryotherapy. Indian J Dermatol Venereol Leprol. 2009. 75:262–267.

5. Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006. 4:273–293.

6. Tosti A, Piraccini BM. Warts of the nail unit: surgical and nonsurgical approaches. Dermatol Surg. 2001. 27:235–239.

7. Sammut SJ, Brackley PT, Duncan C, Kelly M, Raraty C, Graham K. Frostbite following use of a commercially available cryotherapy device for the removal of viral warts. Dermatol Online J. 2008. 14:9.

8. Connolly M, Bazmi K, O'Connell M, Lyons JF, Bourke JF. Cryotherapy of viral warts: a sustained 10-s freeze is more effective than the traditional method. Br J Dermatol. 2001. 145:554–557.

9. Ahmed I, Agarwal S, Ilchyshyn A, Charles-Holmes S, Berth-Jones J. Liquid nitrogen cryotherapy of common warts: cryospray vs. cotton wool bud. Br J Dermatol. 2001. 144:1006–1009.

10. Bourke JF, Berth-Jones J, Hutchinson PE. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br J Dermatol. 1995. 132:433–436.

11. Berth-Jones J, Hutchinson PE. Modern treatment of warts: cure rates at 3 and 6 months. Br J Dermatol. 1992. 127:262–265.

12. Kim JE, Kim IH, Son SW. A retrospective analysis of efficacy and recurrence rate for viral warts treated by cryotherapy. Korean J Dermatol. 2006. 44:931–936.

13. Adalatkhah H, Khalilollahi H, Amini N, Sadeghi-Bazargani H. Compared therapeutic efficacy between intralesional bleomycin and cryotherapy for common warts: a randomized clinical trial. Dermatol Online J. 2007. 13:4.

14. Banihashemi M, Pezeshkpoor F, Yazdanpanah MJ, Family S. Efficacy of 80% phenol solution in comparison with cryotherapy in the treatment of common warts of hands. Singapore Med J. 2008. 49:1035–1037.

15. Choi MH, Seo SH, Kim IH, Son SW. Comparative study on the sustained efficacy of diphencyprone immunotherapy versus cryotherapy in viral warts. Pediatr Dermatol. 2008. 25:398–399.

16. Focht DR 3rd, Spicer C, Fairchok MP. The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart). Arch Pediatr Adolesc Med. 2002. 156:971–974.

17. Bohlooli S, Mohebipoor A, Mohammadi S, Kouhnavard M, Pashapoor S. Comparative study of fig tree efficacy in the treatment of common warts (Verruca vulgaris) vs. cryotherapy. Int J Dermatol. 2007. 46:524–526.

18. Canpolat F, Cemil BC, Eskioğlu F. Liquid nitrogen cryothearpy of plantar verrucae: cryoblast is more effective than the cryo-spray. Eur J Dermatol. 2008. 18:341–342.

19. Keefe M, Dick DC. Cryotherapy of hand warts--a questionnaire survey of 'consumers'. Clin Exp Dermatol. 1990. 15:260–263.

20. Bunney MH, Nolan MW, Williams DA. An assessment of methods of treating viral warts by comparative treatment trials based on a standard design. Br J Dermatol. 1976. 94:667–679.

21. Grussendorf-Conen EI, Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol. 2002. 19:263–266.

22. Upitis JA, Krol A. The use of diphenylcyclopropenone in the treatment of recalcitrant warts. J Cutan Med Surg. 2002. 6:214–217.

23. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg. 2005. 31:674–686. discussion 686.

24. Eryilmaz T, Tuncer S, Uygur S, Ayhan S. Finger tip defect after cryotherapy. Dermatol Surg. 2009. 35:550–551.